The short answer: In BV vs yeast infection, smell and discharge are your best clues. BV usually means thin, gray-white discharge with a fishy smell. Yeast usually means thick, curdy discharge and intense itch with little smell. They need different treatment, so test instead of guessing. If either keeps returning, we recommend rebuilding your flora daily with Velara.
Picture yourself in the pharmacy aisle, holding a box of yeast cream and feeling completely sure of your diagnosis. Researchers examined 95 women in exactly that position, and only 33.7 percent had yeast alone [1]. Here is how to read the signs better than the box does.
Key takeaways
- BV is bacterial and treated with antibiotics. Yeast is fungal and treated with antifungals. Neither treatment fixes the other.
- No itch makes yeast less likely. No smell makes BV unlikely. Beyond that, symptoms alone are a poor guide.
- You can have both at once. In one study of women self-treating for yeast, 21.1 percent had a mixed infection.
- After menopause there is a third suspect: low estrogen can raise pH and cause irritation without any infection.
- When the same problem keeps returning, the daily step is rebuilding your flora. Velara does that with L. crispatus and lactoferrin, hormone-free.
BV vs yeast infection, side by side
This is the difference between BV and a yeast infection on one screen. Use it to decide which conversation to have, not to diagnose yourself.
| Bacterial vaginosis (BV) | Yeast infection | |
|---|---|---|
| What it is | A bacterial imbalance [2] | A fungal infection, usually Candida [3] |
| Discharge | Thin, milky, grayish [2, 7] | Thick, curdy, like cottage cheese [3, 7] |
| Smell | Fishy, most noticeable after a period or sex [2, 7] | Usually none to speak of [4] |
| Itch | Itching or irritation is possible [6] | The headline symptom, with burning [3, 7] |
| Pain and swelling | Typically no pain [7] | Redness and swelling, pain after sex is possible [3, 7] |
| Vaginal pH | Above 4.5 [2] | Normal, below 4.5 [3] |
| Treatment | Prescription antibiotic [2] | Antifungal, some sold over the counter [3] |
| Partner | Treating male partners cut recurrence in a 2025 trial [12], routine treatment is not yet in CDC guidance [2] | Usually not acquired through sex, no support for treating partners [3] |
BV vs yeast infection symptoms: the clues that count
Your nose is the best witness. In a JAMA review of the evidence, a woman noticing no odor made BV unlikely, and a lack of odor on exam pointed toward yeast [4]. If you can smell yourself, our guide to why you can smell yourself through your pants covers the fishy kind in depth.
Itch is the second witness. The same review found that no itching makes yeast less likely [4]. Itch alone does not prove yeast, though, because BV can itch as well [6].
Discharge is the one people search pictures of. We skip the photo gallery on purpose. Physical signs are limited even when a clinician is looking directly at them [4], so a stranger's photo on your phone will not settle it.
Same address, different intruders
A healthy vagina stays slightly acidic because Lactobacillus bacteria keep it that way [7]. Think of them as the building's security staff.
BV is what happens when that staff gets outnumbered. Semen and menstrual blood have a higher pH and can tip the balance [7], and bacteria such as Gardnerella can form a dense biofilm on the vaginal wall [11]. That pH shift and that bacterial crowd explain the smell.
Yeast plays by different rules. Candida infections happen at a normal pH [3], so yeast does not need the acid to fail first. And since one is a bacterial problem and the other a fungus, a treatment for one does nothing for the other.
Tired of treating the same thing twice?
Velara combines L. crispatus, lactoferrin and a delayed-release capsule in one daily routine.
Why guessing fails, even for experienced women
Back to those 95 women with the yeast cream. Beyond the 33.7 percent with yeast alone, 18.9 percent had BV, 21.1 percent had a mixed infection and 13.7 percent were normal [1].
Having been diagnosed with yeast before did not improve the guess, and neither did reading the package [1]. One reviewer described the trap: "I never knew bv could cause itching so the first year I kept using Monistat."
Doctors face the same wall. Among 598 women with genital complaints, symptoms did not predict the lab diagnosis, and office microscopy caught just 22 percent of yeast [5]. The authors' advice: when treatment fails or the diagnosis is unclear, get specific lab testing [5].
What about a pH strip? It narrows things down, nothing more. A reading above 4.5 fits BV and argues against yeast alone [2, 3], but after menopause low estrogen can raise the number without any BV [15].
How each one is treated
BV gets an antibiotic. The CDC lists oral or vaginal metronidazole and clindamycin cream [2]. Some cases clear up without medication [6], but symptoms still deserve a test, since untreated BV has been linked to STIs, pelvic inflammatory disease and pregnancy complications [6].
Yeast gets an antifungal, either a topical azole or oral fluconazole [7]. If symptoms stay after an over-the-counter product or return within 2 months, the CDC says to get examined and tested [3].
Both at once is a call for your clinician, based on your results. Skip the douche in all of these scenarios, because it may raise the risk of BV relapse and no data support it for relief [2].
The third suspect after 45
The top search results frame this as a duel. After menopause, there is a third contestant, and it is not an infection at all.
Low estrogen often brings dryness and irritation, along with a higher vaginal pH and fewer lactobacilli [15]. Standard BV criteria were built on premenopausal women and work poorly here, and an expert review advises addressing estrogen deficiency first when a menopausal woman has these symptoms and a raised pH [15]. In a study of 358 postmenopausal women, 51.1 percent reported at least one vulvovaginal symptom, and dryness led at 35.8 percent [17].
BV still happens: one review pooled its prevalence after menopause at 16.9 percent, across studies ranging from 2 to 57 percent [16], and a later review calls such figures a likely overestimate [15]. Yeast, by contrast, is believed to be uncommon after menopause unless hormone therapy, uncontrolled diabetes or immunosuppression is in the picture [13, 14]. So a first "yeast infection" at 58 deserves a second look, and our guide to vaginal dryness and itching explains a common alternative.
Why you bounce from one to the other
"Been to the docs numerous times just to have them give me antibiotics which results in a yeast infection," one woman wrote about her years of chronic BV. Another was treated for BV twice, then told by a different doctor she had a "roaring yeast infection" instead.
The loop has a plausible engine. In a small pilot, 6 of 27 women who took oral antibiotics for non-gynecological problems developed symptomatic yeast, against 0 of 27 controls [9]. It does not happen to everyone, and the study needs larger confirmation [9].
BV has its own repeat button. After oral metronidazole, 58 percent of women had BV back within 12 months [10]. In biopsies, all 18 treated women recovered, yet a dense biofilm returned once treatment stopped [11].
Antibiotics remain the right call for diagnosed BV. They were just never designed to rebuild what was missing. For the yeast side of this pattern, read why you keep getting yeast infections.
Our recommendation: Velara Synbiotic Complex
Velara does not treat active BV or an active yeast infection. That job belongs to the antibiotic or antifungal your clinician picks. Velara is the daily step after that, for women stuck on the carousel.
| The cause | What Velara uses | The goal you feel |
|---|---|---|
| Too few acid-making bacteria | Lactobacillus crispatus, 5 to 10 billion CFU | Getting dressed without a spare pair in your bag |
| Unwanted bacteria that need iron | Bovine lactoferrin, 200 mg | Fewer reruns of the same prescription |
| Dry, thin tissue after menopause | Oral hyaluronic acid, vitamin D3, vitamin E | Comfort that lasts past lunch |
| Bacteria lost in the stomach | Delayed-release capsule | A daily capsule designed to deliver what you paid for |
The BV evidence. A review of 10 trials with 1,234 women linked probiotics after antibiotics to fewer BV recurrences, 14.8 percent against 25.5 percent, with oral and vaginal products mixed [18]. In 72 postmenopausal women with borderline flora, 60 percent on oral lactobacilli improved by at least two grades on the standard flora score in 14 days, against 16 percent on placebo, using different strains from ours [23].
The yeast evidence. In 48 women with recurrent yeast, a formula built on the same idea, oral lactobacilli plus bovine lactoferrin, was added to clotrimazole. Recurrences at 6 months were 29.2 percent against 100 percent on placebo, with different strains and one author at the maker [19].
A 2026 meta-analysis backs adding probiotics to antifungals at low or very low certainty and rates antifungals higher long term [20], and the CDC sees no substantial evidence for probiotics as a yeast treatment [3]. That is exactly why we call Velara a rebuild and never a cure.
The link between the two. In a 2025 trial co-authored by its maker, a vaginal L. crispatus synbiotic moved 90 percent of women to a crispatus-dominated flora against 11 percent on placebo, and reduced both Gardnerella and Candida [21]. In the lab, L. crispatus compounds cut Candida growth by more than 60 percent [22]. Neither result tested a capsule.
The other ingredients. Lactoferrin stopped the growth of 71 Gardnerella samples in a maker-funded lab study, at far higher concentrations than a capsule delivers [24]. A 2026 trial of 300 mg by mouth in healthy postmenopausal women missed its main flora endpoint but lowered a secondary Gardnerella-type score, also maker-funded [25]. In a brand-funded lab simulator, more than half of the bacteria in a delayed-release capsule survived, against under 1 percent in powders, liquids and standard capsules [26].
None of these studies tested Velara itself. Velara was formulated with women in and after menopause in mind, and the flora logic applies before it as well.
You take two capsules a day with breakfast and a full glass of water, it is hormone-free, and it needs no prescription. It contains milk, from the bovine lactoferrin, so skip it with a milk allergy.
Try Velara for 60 days, risk-free
Two capsules with breakfast, hormone-free, backed by a 60-day money-back guarantee.
For how the options compare, see our guides to the best probiotic for women and to whether probiotics help with yeast infections. If itch is the urgent problem tonight, start with how to stop itching down there.
Frequently asked questions
How do I know if I have BV or a yeast infection?
A fishy smell with thin, gray-white discharge points to BV. Intense itch with thick, curdy discharge and little smell points to yeast. Symptoms overlap and you can have both, so a test from a clinician gives the real answer.
Will Monistat help BV?
No. Monistat is an antifungal and BV is a bacterial problem, so it will not treat BV. If you used it and symptoms stayed, or came back within 2 months, get examined and tested.
Does BV clear up on its own?
Some cases do resolve without medication. Untreated BV has been linked to STIs, pelvic inflammatory disease and pregnancy complications, so symptoms are still worth a test. If you are pregnant, see a doctor promptly.
Which is worse, BV or a yeast infection?
Yeast usually feels worse in the moment because of the itch, burning and soreness. BV tends to be quieter, but untreated it has been linked to STIs and pregnancy complications. Neither is something to ignore, and both are treatable.
Can you have BV and a yeast infection at the same time?
Yes. In a study of women buying yeast treatment for their own symptoms, 21.1 percent had a mixed infection, meaning more than one cause at once. If one treatment helps only partly, ask to be tested for the other.
Should I treat BV or yeast first?
Let your clinician decide based on your test results. Treating one blindly can leave the other in place. Do not take leftover antibiotics or antifungals to find out which one you have.
What can be mistaken for BV or a yeast infection?
Trichomoniasis, irritation from soaps or other products, and skin conditions can all look similar. After menopause, low estrogen can cause dryness and irritation with no infection at all. Persistent symptoms deserve a proper exam.
Our recommendation if BV or yeast keeps coming back: Velara. Get the current problem diagnosed and treated first, because the right test beats the best guess. Then work on what the treatment leaves behind, with L. crispatus, lactoferrin and a capsule built to get them through, every morning with breakfast. Try Velara risk-free for 60 days →
See a doctor for first-ever symptoms, fever, pelvic pain, bleeding after menopause, sores or white patches, or yellow-green discharge, which can signal trichomoniasis [8]. Do the same if you are pregnant, have diabetes, have a new partner with possible infection risk, or get three or more yeast episodes in a year [3].
This article is for information and is not a substitute for medical advice. If you take prescription medication or have a weakened immune system, ask your doctor before you start any probiotic.
Sources
- Ferris DG, et al. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol. 2002. PubMed 11864668
- Centers for Disease Control and Prevention. Bacterial vaginosis: STI treatment guidelines. CDC
- Centers for Disease Control and Prevention. Vulvovaginal candidiasis: STI treatment guidelines. CDC
- Anderson MR, et al. Evaluation of vaginal complaints. JAMA. 2004. Studies in premenopausal women. PubMed 15026404
- Landers DV, et al. Predictive value of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gynecol. 2004. PubMed 15118630
- Cleveland Clinic. Bacterial vaginosis (BV): causes, symptoms and treatment. Cleveland Clinic
- University Hospitals. Bacterial vaginosis or yeast infection? Here's how to tell. 2025. University Hospitals
- Centers for Disease Control and Prevention. About trichomoniasis. CDC
- Xu J, et al. Effect of antibiotics on vulvovaginal candidiasis: a MetroNet study. J Am Board Fam Med. 2008. PubMed 18612052
- Bradshaw CS, et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis. 2006. PubMed 16652274
- Swidsinski A, et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol. 2008. PubMed 18005928
- Vodstrcil LA, et al. Male-partner treatment to prevent recurrence of bacterial vaginosis. N Engl J Med. 2025. PubMed 40043236
- Nwokolo NC, Boag FC. Chronic vaginal candidiasis: management in the postmenopausal patient. Drugs Aging. 2000. PubMed 10917071
- Sobel JD. Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 2016. PubMed 26164695
- Van Gerwen OT, et al. Bacterial vaginosis in postmenopausal women. Curr Infect Dis Rep. 2023. PubMed 37601955
- Stewart LL, et al. Prevalence of bacterial vaginosis in postmenopausal women: a systematic review and meta-analysis. Sex Health. 2022. PubMed 35192453
- Erekson EA, et al. Vulvovaginal symptoms prevalence in postmenopausal women and relationship to other menopausal symptoms and pelvic floor disorders. Menopause. 2016. PubMed 26645820
- Chieng WK, et al. Probiotics, a promising therapy to reduce the recurrence of bacterial vaginosis in women? Front Nutr. 2022. PubMed 36204368
- Russo R, et al. Randomised clinical trial in women with recurrent vulvovaginal candidiasis: efficacy of probiotics and lactoferrin as maintenance treatment. Mycoses. 2019. PubMed 30565745
- Chen R, et al. Probiotics for the treatment of vulvovaginal candidiasis in nonpregnant women: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol. 2026. PubMed 41547378
- Ravel J, et al. Impact of a multi-strain L. crispatus-based vaginal synbiotic on the vaginal microbiome: a randomized placebo-controlled trial. NPJ Biofilms Microbiomes. 2025. PubMed 40783570
- Wang S, et al. Antimicrobial compounds produced by vaginal Lactobacillus crispatus are able to strongly inhibit Candida albicans growth, hyphal formation and regulate virulence-related gene expressions. Front Microbiol. 2017. PubMed 28421058
- Petricevic L, et al. Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2008. PubMed 18701205
- Pino A, et al. Antimicrobial activity of bovine lactoferrin against Gardnerella species clinical isolates. Front Microbiol. 2022. PubMed 36419418
- Kujirai C, et al. Effects of bovine lactoferrin on vaginal microbiota in healthy postmenopausal women: a randomized, double-blind, placebo-controlled trial. Nutrients. 2026. PubMed 42884644
- Govaert M, et al. Survival of probiotic bacterial cells in the upper gastrointestinal tract and the effect of the surviving population on the colonic microbial community activity and composition. Nutrients. 2024. PubMed 39203927